genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2013
Adrenal cancer
Insights
Getting Around “Undruggable” Proto-Oncogenes
Cancer
Apeiron Out-Licenses Antibody-Based Immunotherapy
Cancer
Childhood Cancer-Linked Mutations May Point Toward New Targets
Industry News
Abingdon Health Raises £3M to Buy 50.1% of POC Dx Firm Molecular Vision
Cancer
New BRCA1-Associated Breast Cancer Susceptibility Gene Identified
Cancer
Apeiron Gains Rights to Phase III-Stage Neuroblastoma Treatment
Cancer
Apeiron Nabs Option to Cleveland Clinic’s Preclincial SHP-1 Inhibitors
Cancer
Lpath Bags $2M Asonep Milestone from Merck KGaA and then Severs Ties
News
T Lymphocytes with Specificity to Epstein-Barr and Artificial Receptor Can Help Cells Fight Neuroblastoma
News
Researchers Link Five Mutations in One Gene to Neuroblastoma
1
2
3
Page 2 of 3
Scroll Up
Scroll Up
